November's wave of FDA oncology approvals signals the industry's shift toward platform-based precision therapies over broad-spectrum approaches([1]) . The global anticancer drug market now values ...

In 2025, Anthropic will grow from $1 billion to $9 billion in ARR (annual recurring revenue). OpenAI, meanwhile, will go from ...

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

Bowen Yang is leaving “Saturday Night Live” after this weekend’s Christmas show, in the middle of Season 51. “He has been ...

The Arts Council of Princeton (ACP) has announced a three-person exhibition, “Divergent Forms,” featuring the work of artists ...

The Central Board of Secondary Education has announced a revised timetable for Class 10 board exams 2026, rescheduling ...

Follow the steps below to download the CBSE Time Table 2026 PDF for Classes 10 and 12 from the official CBSE website: Visit the official CBSE website: Go to cbse.gov.in. Click on the “Main Website” ...

Bihar Board 12th Question Paper 2025: The Bihar School Examination Board (BSEB) has released the Bihar Board Class 12 Exam Routine 2026. As per the BSEB Inter Routine 2026, the Class 12 board exams ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the most active US stocks to buy according to analysts. On December 8, ...

Before market open, Recursion divulged that its REC-4881 demonstrated notable efficacy in a phase 1b/2 trial. The drug, which treats a disorder called familial adenomatous polyposis (FAP) in which ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...